Flavia Foca

19PUBLICATIONS
101CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Mar 28, 2026
Prostate-Specific Membrane Antigen (PSMA): A Potential Theranostic Biomarker in Breast Cancer.

Alessandra Virga, Flavia Foca, Stefania Cortecchia

|Nov 27, 2025
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study.

Irene Marini, Emilio Francesco Giunta, Silvia Nicolini

|May 25, 2024
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("PEMBROREAL" Study).

Alessandro Cafaro, Flavia Foca, Oriana Nanni

|Feb 10, 2024
Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer Patients.

Nicola Gentili, William Balzi, Flavia Foca

|Aug 26, 2023
Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric Cancer.

Manlio Monti, Andrea Prochowski Iamurri, David Bianchini

|Jun 30, 2023
Predicting Functional Recovery and Quality of Life in Older Patients Undergoing Colorectal Cancer Surgery: Real-World Data From the International GOSAFE Study.

Isacco Montroni, Giampaolo Ugolini, Nicole M Saur

Pageof 4

Frequent Collaborators

4 joint publications

Alberto Bongiovanni

4 joint publications

Toni Ibrahim

3 joint publications

Federica Matteucci

3 joint publications

Nicoletta Ranallo